DavidNorrisMD
Dermatology • Aurora, COProfesor and Chairman Department of Dermatology UNiversity of Colorado Denver
Dr. Norris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
12401 E 17th Ave
Ste F417
Aurora, CO 80045Phone+1 720-848-0000Fax+1 303-315-7280- Is this information wrong?
Summary
- I am a board certified dermatologist specializing in autoimmune skin diseases and skin cancers, including melanoma.
My research interests match my clinical interests. I am chairman of a strong academic Dermatology Department with 35 faculty including 20 Ph.D. scientists.
Education & Training
University of ColoradoResidency, Dermatology, 1974 - 1977- University of Colorado School of MedicineInternship, Transitional Year, 1973 - 1974
Ohio State University HospitalInternship, Internal Medicine, 1973 - 1974
Duke University HospitalFellowship, Allergy and Immunology, 1971 - 1973
Duke University School of MedicineClass of 1973
Certifications & Licensure
CO State Medical License 1975 - 2025- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatological Immunology/Diagnostic & Laboratory Immunology
Awards, Honors, & Recognition
- President American Skin Association
- Member of the Board of Scientific Counsellors, Clinical/Epidemiology National Cancer Institute
- Editor in Chief Journal of Investigative Dermatology, 1987-1992
- Join now to see all
Clinical Trials
- Alopecia Areata Registry Start of enrollment: 2001 Nov 01
Publications & Presentations
PubMed
- MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade.Mukherjee, N., Katsnelson, E., Brunetti, T., Michel, K., Couts, K., Lambert, K., Tobin, R., Shellman, Y., Robinson, W., McCarter, M., Norris, D.> ;Cell Death & Disease. 2024 Mar 8
- Vitiligo non-responding lesions to narrow band UVB have intriguing cellular and molecular abnormalities that may prevent epidermal repigmentation.Nathaniel B Goldstein, Andrea Steel, Landon Tomb, Zachary Berk, Junxiao Hu, Velmurugan Balaya, Laura Hoaglin, Kavya Ganuthula, Meet Patel, Erica Mbika, William A Robin...> ;Pigment Cell & Melanoma Research. 2024 May 1
- 1 citationsCommonly prescribed medications associated with alopecia.Jessica Mounessa, Joseph V Caravaglio, Renee Domozych, Stephanie Chapman, Robert P Dellavalle, Cory A Dunnick, David Norris> ;Journal of the American Academy of Dermatology. 2023 Jun 1
- Join now to see all
Press Mentions
Will Smith's Slap at the Oscars Awakens the World to Alopecia AreataApril 12th, 2022
John E. Harris, MD, PhD, 2019 American Skin Association Calder Research Scholar Award in Vitiligo and Pigment Cell Disorders Recipient Receives the Presidential Early Career Award for Scientists and Engineers by United States GovernmentJuly 11th, 2019
Castle Biosciences Receives 2019 Technology Innovation in Melanoma Award from American Skin AssociationApril 24th, 2019- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
Denver HealthDenver, Colorado
Rocky Mountain Regional VA Medical CenterAurora, Colorado
UCHealth Memorial HospitalColorado Springs, Colorado
University of Colorado HospitalAurora, Colorado
UCHealth Poudre Valley HospitalFort Collins, Colorado
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
